Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Adjuvant S-1 prolongs survival among patients with resected biliary tract cancer
Adjuvant S-1 therapy significantly extended survival compared with surgery alone among patients with resected biliary tract cancer, according to results of a study conducted in Japan and presented at ASCO Gastrointestinal Cancers Symposium.
Beta blocker use does not affect outcomes in immunotherapy-treated HCC
Use of beta blockers did not affect outcomes among patients treated with immunotherapy for unresectable hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
Log in or Sign up for Free to view tailored content for your specialty!
Pembrolizumab extends survival among patients with advanced hepatocellular carcinoma
Pembrolizumab conferred a small but statistically significant survival benefit when added to best supportive care as second-line treatment for patients with advanced hepatocellular carcinoma, according to a phase 3 study conducted in Asia.
Libtayo effective in killing HCC tumors prior to resection
Neoadjuvant immunotherapy Libtayo administered before surgical resection led to tumor necrosis in about one-third of patients with hepatocellular carcinoma, according to data published in The Lancet Gastroenterology and Hepatology.
Racial, ethnic disparities in patients with HCC reveal need to reduce barriers to care
Among patients newly diagnosed with hepatocellular carcinoma, there are significant racial and ethnic differences in barriers to care, according to survey results published in Clinical Gastroenterology and Hepatology.
With rising HBV burden, experts say it is critical to implement new vaccine guideline
The CDC’s Advisory Committee on Immunization Practices recently issued a universal recommendation that all adults aged 19 to 59 years receive the hepatitis B vaccine.
Rates of HCC rising in Black patients without cirrhosis
In the era of direct-acting antivirals, rates of hepatocellular carcinoma are rising in patients without cirrhosis, particularly Black patients, according to a presentation at The Liver Meeting Digital Experience.
10 recent reports from The Liver Meeting Digital Experience
Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.
FDA grants orphan drug status to rivoceranib for hepatocellular carcinoma
The FDA granted orphan drug designation to rivoceranib for the treatment of hepatocellular carcinoma.
Combinatorial serum protein panel ‘promising’ in early HCC detection
Use of a transforming growth factor-beta pathway-based combinatorial serum protein panel may aid in the early detection of hepatocellular carcinoma, according to research presented at The Liver Meeting Digital Experience.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read